Hyderabad-based Bharat Biotech will attend the pre-submission meeting for emergency use listing of Covaxin by the World Health Organization on Wednesday. The WHO had accepted Bharat Biotech's Expression of Interest for Covaxin on June 18. As per WHO guidelines, EUL is a procedure to streamline the process by which new or unlicenced products can be used during public health emergencies.